✅ Product Benefits

1. Dual action for diabetes and heart health — Lowers blood glucose while reducing cardiovascular mortality risk in type 2 diabetes patients with established cardiovascular disease .

2. Once-daily dosing — Convenient single-dose regimen enhances patient adherence .

3. No renal dose adjustment — Suitable for patients with mild to moderate renal impairment .

4. Minimal drug interactions — Weak inhibitor of CYP3A4; low risk of significant drug-drug interactions .

5. No weight gain — Unlike some other diabetes medications, Emjard does not typically cause weight gain .

6. Low risk of hypoglycemia — When used alone or with metformin, Emjard has a low risk of causing low blood sugar .

7. Flexible administration — Can be taken with or without food, offering flexibility in daily routines .